{"id":2023,"date":"2025-06-27T10:47:05","date_gmt":"2025-06-27T10:47:05","guid":{"rendered":"https:\/\/xraise.ai\/blog\/?p=2023"},"modified":"2025-06-27T10:47:07","modified_gmt":"2025-06-27T10:47:07","slug":"angel-investor-andrew-ackerman","status":"publish","type":"post","link":"https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/","title":{"rendered":"Andrew Ackerman: De-Risking Startups, Fast"},"content":{"rendered":"\n<p>You\u2019ve landed pilots, burned half your seed round, and larger VCs still say, \u201cToo early\u2014come back with proof.\u201d \ud83d\ude29 That <strong>execution gap<\/strong> kills more <strong>B2B healthtech<\/strong> and <strong>cybersecurity startups<\/strong> than competition ever will.<br>Enter <strong>Andrew Ackerman<\/strong>, General Partner at <strong>Dreamit Ventures<\/strong>. His entire model\u2014<strong>&#8220;de-risk, then scale&#8221;<\/strong>\u2014is built to get you over that chasm in record time. \u23f1\ufe0f If you\u2019re <strong>pre-Series A<\/strong> and need both <strong>capital<\/strong> \ud83d\udcb0 <strong>and<\/strong> enterprise-customer access \ud83c\udfe5, Andrew Ackerman is the investor you need to study.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Who Is Andrew Ackerman and Why Founders Listen<\/h2>\n\n\n\n<p>Ackerman isn\u2019t your typical VC\u2014he brings a blend of Wall Street precision and hands-on startup savvy. Founders turn to him not just for capital, but for his strategic mind and de-risking frameworks that bridge the seed-to-Series A chasm. Here&#8217;s why startup operators across healthtech and Securetech trust him to level up their game:<\/p>\n\n\n\n<p>\u2022 \ud83d\udcbc Former <strong>Wasserstein Perella investment banker<\/strong> who speaks fluent numbers and nose-bleeds on valuation.<br>\u2022 \ud83d\udcca Runs <strong>Dreamit\u2019s Securetech vertical<\/strong> and co-leads Healthtech, deploying ~$375k average checks into 4-8 companies per year.<br>\u2022 \ud83c\udfc1 Credited with exits to <strong>Illumina, bioM\u00e9rieux, RELX, and SAGE Publishing<\/strong>\u2014validation that his &#8220;de-risk&#8221; mantra works.<br>\u2022 \u26a1 Leads Dreamit\u2019s famous <strong>2-week diligence sprints<\/strong>, giving founders clarity\u2014fast\u2014on whether a deal moves forward.<br>\u2022 \ud83c\udfa4 Active <strong>Wharton mentor &amp; conference speaker<\/strong>; his network has opened doors to HIMSS, AWS, and Phorum stages.<br><strong>One-liner<\/strong>: Andrew Ackerman is the <strong>hands-on GP who turns risky seed plays into Series A-ready traction machines<\/strong>.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Andrew Ackerman\u2019s Thesis \u2014 \u201cDe-Risk or Die\u201d<\/h2>\n\n\n\n<p>Ackerman doesn\u2019t bet on potential\u2014he bets on <strong>traction, clarity, and repeatability<\/strong>. His thesis is simple but powerful: great technology only becomes great business when risk is removed from the equation. Ackerman believes great tech dies when milestones are fuzzy.<\/p>\n\n\n\n<p><strong>Core pillars:<\/strong><br>\u2022 \u2705 <strong>Customer Validation First<\/strong> \u2013 pilots or paid POCs before a penny of scale spend.<br>\u2022 \ud83d\udd12 <strong>Regulatory &amp; Security Clarity<\/strong> \u2013 FDA pathway or SOC 2 roadmap locked by seed.<br>\u2022 \ud83d\udee0\ufe0f <strong>Enterprise-Ready GTM<\/strong> \u2013 repeatable sales motion with at least two reference customers.<br>\u2022 \ud83d\udca1 <strong>Capital-Efficient Builds<\/strong> \u2013 budgets tied to milestone gates; no fat teams pre-product-market-fit.<br>\u2022 \ud83c\udf0d <strong>Diversity as Alpha<\/strong> \u2013 &gt;35% female founders &amp; 25% under-represented reflect broader B2B markets.<br><strong>Takeaway<\/strong>: Show how fresh capital slashes risk, not how it props up vanity metrics, and you\u2019re speaking Ackerman\u2019s language.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Angel Deal Terms at a Glance \u2014 Ackerman\u2019s Sweet Spot<\/h2>\n\n\n\n<p>Dreamit invests from a fund, but you\u2019ll negotiate directly with Andrew Ackerman.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Stage<\/th><th>Typical Check<\/th><th>Sectors<\/th><th>Geography<\/th><\/tr><\/thead><tbody><tr><td>Pre-Seed<\/td><td>$250k-$300k<\/td><td>Healthtech, Securetech<\/td><td>USA, Canada, Israel<\/td><\/tr><tr><td>Seed (majority)<\/td><td>~$375k<\/td><td>Healthtech, Cyber SaaS<\/td><td>Same<\/td><\/tr><tr><td>Bridge\/Seed+<\/td><td>Up to $500k<\/td><td>Existing portfolio<\/td><td>Global<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Takeaway<\/strong>: If you\u2019re B2B health or security tech, raising \u2264 $3M, Ackerman can be your lead or insider anchor.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">What Andrew Ackerman Looks For (Beyond the Hype)<\/h2>\n\n\n\n<p>This isn\u2019t about charisma or vision decks\u2014it\u2019s about <em>proof<\/em>. Before Ackerman wires a dollar, he needs to know you\u2019ve done the gritty work of proving real customer pain and solution fit. Here\u2019s the kind of founder profile and traction that gets a yes.<\/p>\n\n\n\n<p>\u2022 \ud83e\udde0 <strong>Deep domain founders<\/strong> \u2013 years in the problem space, not MBA tourists.<br>\u2022 \ud83d\udcc4 <strong>Evidence of pay-to-solve pain<\/strong> \u2013 pilots or LOIs trump prototypes.<br>\u2022 \ud83d\udcac <strong>Coachability<\/strong> \u2013 founders who debate hard, then execute harder.<br>\u2022 \ud83c\udfaf <strong>Clear milestone map<\/strong> \u2013 12-month plan aimed squarely at Series A criteria.<br>\u2022 \ud83d\udd25 <strong>Lean burn<\/strong> \u2013 sub-$100k monthly post-raise shows fiscal discipline.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Inside Andrew Ackerman\u2019s Portfolio<\/h2>\n\n\n\n<p>Ackerman\u2019s picks reveal his pattern recognition.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Company<\/th><th>Sector<\/th><th>Round<\/th><th>Why It Fits Ackerman\u2019s Thesis<\/th><\/tr><\/thead><tbody><tr><td>Emedgene<\/td><td>Healthtech AI<\/td><td>Seed<\/td><td>Clear FDA path + genomic pilots \u2192 acquired by Illumina \ud83d\ude80<\/td><\/tr><tr><td>Biomeme<\/td><td>Diagnostics<\/td><td>Seed<\/td><td>Paid hospital pilots; efficient hardware-plus-SaaS model<\/td><\/tr><tr><td>Raxar<\/td><td>Enterprise SaaS<\/td><td>Seed<\/td><td>Asset mgmt for infra\u2014mission-critical, sticky customers<\/td><\/tr><tr><td>SentiAR<\/td><td>AR Healthtech<\/td><td>Seed<\/td><td>Clinical validation &amp; surgeon co-founder credibility<\/td><\/tr><tr><td>Aikido Security<\/td><td>Securetech SaaS<\/td><td>Pre-Seed<\/td><td>Security teams as early design partners, high ARR potential<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Takeaway<\/strong>: Each deal answered the \u201clargest risk?\u201d question before money hit the bank.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Cold Outreach Playbook: Stand Out in Ackerman\u2019s Inbox<\/h2>\n\n\n\n<p><strong>Subject<\/strong>: \u201c2 risky bets already de-risked\u201415 min?\u201d<br>\u2022 \u2709\ufe0f <strong>Line 1<\/strong>: One-sentence problem &amp; ICP (\u201cHospitals lose $4B to surgical delays annually\u201d).<br>\u2022 \ud83d\udcc8 <strong>Line 2<\/strong>: Traction metric that kills doubt (e.g., \u201c3 paid pilots, $120k ARR\u201d).<br>\u2022 \ud83d\udd0e <strong>Line 3<\/strong>: Why risk profile now fundable (\u201cFDA 510(k) path cleared; SOC 2 underway\u201d).<br>\u2022 \ud83c\udfaf <strong>Line 4<\/strong>: Specific ask (\u201cSeeking $2.5M seed; $375k fit your sweet spot?\u201d).<br>\u2022 \ud83d\udd17 <strong>Line 5<\/strong>: Link to deck + Dreamit application page.<br><strong>Skip the fluff<\/strong>\u2014Ackerman scans for risk-killer bullets, not origin stories.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Life After the Wire: What Founders Actually Get<\/h2>\n\n\n\n<p>The check clears\u2014but what happens next? With Ackerman, it\u2019s not just post-wire support; it\u2019s an acceleration phase designed to hit enterprise-grade milestones. Here\u2019s what founders actually receive once they\u2019re in the Dreamit fold:<\/p>\n\n\n\n<p>\u2022 \ud83d\ude80 <strong>Customer Sprints<\/strong> \u2013 30-day blitz of Fortune 500 &amp; top-hospital meetings, curated by Ackerman\u2019s team.<br>\u2022 \ud83e\uddfe <strong>Board-level prep<\/strong> \u2013 narrative, data room, and KPI benchmarks for Series A intros.<br>\u2022 \ud83e\uddd1\u200d\ud83d\udcbb <strong>Tactical talent help<\/strong> \u2013 vetted security engineers &amp; health-data scientists from the Dreamit network.<br><strong>Anecdote<\/strong>: Raxar\u2019s CEO credits \u201cone Ackerman-intro call during a Sprint\u201d that converted into a $500k annual contract\u2014validating ARR to land their $8M Series A (Source: Dreamit blog interview).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Red Flags That Make Ackerman Ghost Your Round<\/h2>\n\n\n\n<p>Ackerman isn\u2019t afraid to move fast\u2014but only when key risks are addressed head-on. If your pitch skips over critical proof points or pretends red flags don\u2019t exist, you won\u2019t get a second chance. Founders say the quickest way to a \u201cpass\u201d email is ignoring risk.<\/p>\n\n\n\n<p>\u2022 \u274c No grasp of customer pain or buying process.<br>\u2022 \ud83d\udeab Pure B2C or D2C models\u2014outside mandate.<br>\u2022 \ud83d\udd25 Burn &gt; $150k\/mo pre-product-market fit.<br>\u2022 \ud83e\uddea Vague regulatory path for health devices.<br>\u2022 \ud83d\ude45\u200d\u2642\ufe0f Founders who resist feedback during diligence sprint.<br>\u2022 \ud83d\udcc9 \u201cLand-and-expand\u201d claims without any paid land yet.<br><strong>Takeaway<\/strong>: Strip uncertainty early, or expect silence.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Final Thoughts: Andrew Ackerman as Your Risk-Slayer Co-Pilot<\/h2>\n\n\n\n<p>Raising capital is hard; raising <strong>smart capital<\/strong> is transformational. \ud83d\udca1 Andrew Ackerman couples a <strong>$250k\u2013$500k check<\/strong> with a <strong>repeatable system<\/strong> that replaces <strong>founder guesswork<\/strong> with <strong>enterprise proof<\/strong>. \ud83e\udde0 His <strong>two-week diligence sprint<\/strong> may feel intense, but surviving it means your startup exits with <strong>clearer milestones<\/strong>, <strong>deeper customer pipelines<\/strong>, and a <strong>GP who sells your Series A as fiercely as you do<\/strong>. \ud83d\ude80<\/p>\n\n\n\n<p>If your <strong>B2B healthtech<\/strong> or <strong>cybersecurity startup<\/strong> can already point to <strong>real-world validation<\/strong>\u2014and you\u2019re hungry for a <strong>mentor who will challenge every assumption<\/strong>\u2014submit through <strong>Dreamit\u2019s portal<\/strong> today. \ud83d\udd0d <strong>Because when Ackerman signs, the biggest risk left is not moving fast enough.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Learn how Andrew Ackerman helps startups de-risk fast with capital diligence sprints and B2B traction strategies from Dreamit Ventures.<\/p>\n","protected":false},"author":4,"featured_media":2042,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_title":"Andrew Ackerman: Angel Investor for Risk-Smart Startups","_yoast_wpseo_metadesc":"Learn how Andrew Ackerman helps startups de-risk fast with capital diligence sprints and B2B traction strategies from Dreamit Ventures.","_metasync_otto_title":"","_metasync_otto_description":"","_metasync_otto_keywords":"","_metasync_otto_og_title":"","_metasync_otto_og_description":"","_metasync_otto_twitter_title":"","_metasync_otto_twitter_description":"","rank_math_title":"","rank_math_description":"","_aioseo_title":"","_aioseo_description":"","_metasync_seo_title":"","_metasync_seo_desc":"","_metasync_breadcrumb_title":"","_metasync_primary_category":0,"_metasync_primary_product_cat":0,"_metasync_otto_disabled":"","jnews-multi-image_gallery":[],"jnews_single_post":{"format":"standard"},"jnews_primary_category":[],"jnews_override_bookmark_settings":[],"jnews_override_counter":[],"footnotes":""},"categories":[229],"tags":[],"class_list":["post-2023","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-angel-investors"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Andrew Ackerman: Angel Investor for Risk-Smart Startups<\/title>\n<meta name=\"description\" content=\"Learn how Andrew Ackerman helps startups de-risk fast with capital diligence sprints and B2B traction strategies from Dreamit Ventures.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Andrew Ackerman: De-Risking Startups, Fast\" \/>\n<meta property=\"og:description\" content=\"Learn how Andrew Ackerman helps startups de-risk fast with capital diligence sprints and B2B traction strategies from Dreamit Ventures.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/\" \/>\n<meta property=\"og:site_name\" content=\"XRaise blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-27T10:47:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-27T10:47:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/xraise.ai\/blog\/wp-content\/uploads\/2025\/06\/Andrew-Ackerman1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Henry Miller\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Henry Miller\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/angel-investor-andrew-ackerman\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/angel-investor-andrew-ackerman\\\/\"},\"author\":{\"name\":\"Henry Miller\",\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/#\\\/schema\\\/person\\\/b1fdc5631ba81ab79b56e967afdb758f\"},\"headline\":\"Andrew Ackerman: De-Risking Startups, Fast\",\"datePublished\":\"2025-06-27T10:47:05+00:00\",\"dateModified\":\"2025-06-27T10:47:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/angel-investor-andrew-ackerman\\\/\"},\"wordCount\":1059,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/angel-investor-andrew-ackerman\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Andrew-Ackerman1.jpg\",\"articleSection\":[\"Angel Investors\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/xraise.ai\\\/blog\\\/angel-investor-andrew-ackerman\\\/#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/angel-investor-andrew-ackerman\\\/\",\"url\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/angel-investor-andrew-ackerman\\\/\",\"name\":\"Andrew Ackerman: Angel Investor for Risk-Smart Startups\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/angel-investor-andrew-ackerman\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/angel-investor-andrew-ackerman\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Andrew-Ackerman1.jpg\",\"datePublished\":\"2025-06-27T10:47:05+00:00\",\"dateModified\":\"2025-06-27T10:47:07+00:00\",\"description\":\"Learn how Andrew Ackerman helps startups de-risk fast with capital diligence sprints and B2B traction strategies from Dreamit Ventures.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/angel-investor-andrew-ackerman\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/xraise.ai\\\/blog\\\/angel-investor-andrew-ackerman\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/angel-investor-andrew-ackerman\\\/#primaryimage\",\"url\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Andrew-Ackerman1.jpg\",\"contentUrl\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Andrew-Ackerman1.jpg\",\"width\":1200,\"height\":800,\"caption\":\"Cover image showing Andrew Ackerman, angel investor and Dreamit Ventures GP, known for de-risking B2B startups in healthtech and cybersecurity.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/angel-investor-andrew-ackerman\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Andrew Ackerman: De-Risking Startups, Fast\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/\",\"name\":\"XRaise Blog\",\"description\":\"XRaise Blog provides startup founders with expert insights, resources, and guidance on accelerators, fundraising, and early-stage growth.\",\"publisher\":{\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Organization\",\"Place\"],\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/#organization\",\"name\":\"XRaise\",\"alternateName\":\"XRaise.ai\",\"url\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/\",\"logo\":{\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/angel-investor-andrew-ackerman\\\/#local-main-organization-logo\"},\"image\":{\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/angel-investor-andrew-ackerman\\\/#local-main-organization-logo\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/xraise-ai\\\/\"],\"telephone\":[],\"openingHoursSpecification\":[{\"@type\":\"OpeningHoursSpecification\",\"dayOfWeek\":[\"Monday\",\"Tuesday\",\"Wednesday\",\"Thursday\",\"Friday\",\"Saturday\",\"Sunday\"],\"opens\":\"09:00\",\"closes\":\"17:00\"}]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/#\\\/schema\\\/person\\\/b1fdc5631ba81ab79b56e967afdb758f\",\"name\":\"Henry Miller\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8480af6bd85b632ca2fb16ab994c37f0fc58d1a663fa281e1e824f814f24d9f1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8480af6bd85b632ca2fb16ab994c37f0fc58d1a663fa281e1e824f814f24d9f1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8480af6bd85b632ca2fb16ab994c37f0fc58d1a663fa281e1e824f814f24d9f1?s=96&d=mm&r=g\",\"caption\":\"Henry Miller\"}},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/angel-investor-andrew-ackerman\\\/#local-main-organization-logo\",\"url\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/xraise_ai_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/xraise.ai\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/xraise_ai_logo.jpg\",\"width\":200,\"height\":200,\"caption\":\"XRaise\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Andrew Ackerman: Angel Investor for Risk-Smart Startups","description":"Learn how Andrew Ackerman helps startups de-risk fast with capital diligence sprints and B2B traction strategies from Dreamit Ventures.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/","og_locale":"en_US","og_type":"article","og_title":"Andrew Ackerman: De-Risking Startups, Fast","og_description":"Learn how Andrew Ackerman helps startups de-risk fast with capital diligence sprints and B2B traction strategies from Dreamit Ventures.","og_url":"https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/","og_site_name":"XRaise blog","article_published_time":"2025-06-27T10:47:05+00:00","article_modified_time":"2025-06-27T10:47:07+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/xraise.ai\/blog\/wp-content\/uploads\/2025\/06\/Andrew-Ackerman1.jpg","type":"image\/jpeg"}],"author":"Henry Miller","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Henry Miller","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/#article","isPartOf":{"@id":"https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/"},"author":{"name":"Henry Miller","@id":"https:\/\/xraise.ai\/blog\/#\/schema\/person\/b1fdc5631ba81ab79b56e967afdb758f"},"headline":"Andrew Ackerman: De-Risking Startups, Fast","datePublished":"2025-06-27T10:47:05+00:00","dateModified":"2025-06-27T10:47:07+00:00","mainEntityOfPage":{"@id":"https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/"},"wordCount":1059,"commentCount":0,"publisher":{"@id":"https:\/\/xraise.ai\/blog\/#organization"},"image":{"@id":"https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/#primaryimage"},"thumbnailUrl":"https:\/\/xraise.ai\/blog\/wp-content\/uploads\/2025\/06\/Andrew-Ackerman1.jpg","articleSection":["Angel Investors"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/xraise.ai\/blog\/#organization"}},{"@type":"WebPage","@id":"https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/","url":"https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/","name":"Andrew Ackerman: Angel Investor for Risk-Smart Startups","isPartOf":{"@id":"https:\/\/xraise.ai\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/#primaryimage"},"image":{"@id":"https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/#primaryimage"},"thumbnailUrl":"https:\/\/xraise.ai\/blog\/wp-content\/uploads\/2025\/06\/Andrew-Ackerman1.jpg","datePublished":"2025-06-27T10:47:05+00:00","dateModified":"2025-06-27T10:47:07+00:00","description":"Learn how Andrew Ackerman helps startups de-risk fast with capital diligence sprints and B2B traction strategies from Dreamit Ventures.","breadcrumb":{"@id":"https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/#primaryimage","url":"https:\/\/xraise.ai\/blog\/wp-content\/uploads\/2025\/06\/Andrew-Ackerman1.jpg","contentUrl":"https:\/\/xraise.ai\/blog\/wp-content\/uploads\/2025\/06\/Andrew-Ackerman1.jpg","width":1200,"height":800,"caption":"Cover image showing Andrew Ackerman, angel investor and Dreamit Ventures GP, known for de-risking B2B startups in healthtech and cybersecurity."},{"@type":"BreadcrumbList","@id":"https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/xraise.ai\/blog\/"},{"@type":"ListItem","position":2,"name":"Andrew Ackerman: De-Risking Startups, Fast"}]},{"@type":"WebSite","@id":"https:\/\/xraise.ai\/blog\/#website","url":"https:\/\/xraise.ai\/blog\/","name":"XRaise Blog","description":"XRaise Blog provides startup founders with expert insights, resources, and guidance on accelerators, fundraising, and early-stage growth.","publisher":{"@id":"https:\/\/xraise.ai\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/xraise.ai\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Organization","Place"],"@id":"https:\/\/xraise.ai\/blog\/#organization","name":"XRaise","alternateName":"XRaise.ai","url":"https:\/\/xraise.ai\/blog\/","logo":{"@id":"https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/#local-main-organization-logo"},"image":{"@id":"https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/#local-main-organization-logo"},"sameAs":["https:\/\/www.linkedin.com\/company\/xraise-ai\/"],"telephone":[],"openingHoursSpecification":[{"@type":"OpeningHoursSpecification","dayOfWeek":["Monday","Tuesday","Wednesday","Thursday","Friday","Saturday","Sunday"],"opens":"09:00","closes":"17:00"}]},{"@type":"Person","@id":"https:\/\/xraise.ai\/blog\/#\/schema\/person\/b1fdc5631ba81ab79b56e967afdb758f","name":"Henry Miller","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/8480af6bd85b632ca2fb16ab994c37f0fc58d1a663fa281e1e824f814f24d9f1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8480af6bd85b632ca2fb16ab994c37f0fc58d1a663fa281e1e824f814f24d9f1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8480af6bd85b632ca2fb16ab994c37f0fc58d1a663fa281e1e824f814f24d9f1?s=96&d=mm&r=g","caption":"Henry Miller"}},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/xraise.ai\/blog\/angel-investor-andrew-ackerman\/#local-main-organization-logo","url":"https:\/\/xraise.ai\/blog\/wp-content\/uploads\/2025\/09\/xraise_ai_logo.jpg","contentUrl":"https:\/\/xraise.ai\/blog\/wp-content\/uploads\/2025\/09\/xraise_ai_logo.jpg","width":200,"height":200,"caption":"XRaise"}]}},"_links":{"self":[{"href":"https:\/\/xraise.ai\/blog\/wp-json\/wp\/v2\/posts\/2023","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xraise.ai\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/xraise.ai\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/xraise.ai\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/xraise.ai\/blog\/wp-json\/wp\/v2\/comments?post=2023"}],"version-history":[{"count":1,"href":"https:\/\/xraise.ai\/blog\/wp-json\/wp\/v2\/posts\/2023\/revisions"}],"predecessor-version":[{"id":2024,"href":"https:\/\/xraise.ai\/blog\/wp-json\/wp\/v2\/posts\/2023\/revisions\/2024"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/xraise.ai\/blog\/wp-json\/wp\/v2\/media\/2042"}],"wp:attachment":[{"href":"https:\/\/xraise.ai\/blog\/wp-json\/wp\/v2\/media?parent=2023"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/xraise.ai\/blog\/wp-json\/wp\/v2\/categories?post=2023"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/xraise.ai\/blog\/wp-json\/wp\/v2\/tags?post=2023"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}